Antigeno oligosacarido meningococo grupo a, Antigeno oligosacarido meningococo grupo c, Antigeno oligosacarido meningococo grupo w135, Antigeno oligosacarido meningococo grupo y
Menveo Solucion Inyectable
Packs
| Pack | Code | Status |
|---|---|---|
| MENVEO SOLUCION INYECTABLE, 10 viales de 0,5 ml | 607844 | |
| MENVEO SOLUCION INYECTABLE, 1 vial de 0,5 ml | 766387 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Antigeno oligosacarido meningococo grupo a, Antigeno oligosacarido meningococo grupo c, Antigeno oligosacarido meningococo grupo w135, Antigeno oligosacarido meningococo grupo y
- Strength
- 10 µg + 5 µg + 5 µg + 5 µg
- Dosage form
- solución inyectable
- Route
- vía intramuscular
- Register
- Spain (AEMPS)
- Status
- Marketed
- Status in the register
- Autorizado, comercializado
- Authorised
- 29 Nov 2024
- Registration
- 110614005
- Marketing authorisation holder
- Glaxosmithkline Vaccines S.R.L.
- Procedure
- EU centralised
- Supply
- Medicamento Sujeto A Prescripción Médica